These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265 [TBL] [Abstract][Full Text] [Related]
25. Clinical patterns and risk factors in scleritis: a multicentric study in Colombia. de-la-Torre A; Cabrera-Pérez M; Durán C; García S; Cuevas M; Carreño N; Rangel CM; Pachón-Suárez DI; Martínez-Ceballos MA; Mejía ME; Gómez-Rocha A; Gómez-Durán CA; Pérez Y; Reyes-Guanes J; Cifuentes-González C; Rojas-Carabali W Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3957-3967. PubMed ID: 35796822 [TBL] [Abstract][Full Text] [Related]
26. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Lin P; Bhullar SS; Tessler HH; Goldstein DA Am J Ophthalmol; 2008 Mar; 145(3):463-471. PubMed ID: 18061135 [TBL] [Abstract][Full Text] [Related]
27. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis. Jabbarvand M; Fard MA Ocul Immunol Inflamm; 2010 Jun; 18(3):216-7. PubMed ID: 20482401 [TBL] [Abstract][Full Text] [Related]
29. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209 [TBL] [Abstract][Full Text] [Related]
30. Recalcitrant infective scleritis masquerading an autoimmune necrotising scleritis: a primary presentation of biopsy-proven granulomatosis with polyangiitis. Agarwal R; Tripathi M; Kashyap S; Sharma S BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33472807 [TBL] [Abstract][Full Text] [Related]
31. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment]. Cuchacovich T M; Pacheco P; Merino G; Gallardo P; Gatica H; Valenzuela H; Verdaguer J; Verdaguer J Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507 [TBL] [Abstract][Full Text] [Related]
32. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study. Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic decision in anterior scleritis: our experience at a tertiary care eye center. Carrasco MA; Cohen EJ; Rapuano CJ; Laibson PR J Fr Ophtalmol; 2005 Dec; 28(10):1065-9. PubMed ID: 16395198 [TBL] [Abstract][Full Text] [Related]
34. Infliximab for the treatment of active scleritis. Sen HN; Sangave A; Hammel K; Levy-Clarke G; Nussenblatt RB Can J Ophthalmol; 2009 Jun; 44(3):e9-e12. PubMed ID: 19506593 [TBL] [Abstract][Full Text] [Related]
36. [Study on the clinical manifestation of 90 cases with scleritis and episcleritis]. Zhou Y; Wang Z; Zhang Y; Sun X Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):261-6. PubMed ID: 24931151 [TBL] [Abstract][Full Text] [Related]
37. Bilateral Posterior Scleritis: Analysis of 18 Cases from a Large Cohort of Posterior Scleritis. González-López JJ; Lavric A; Dutta Majumder P; Bansal N; Biswas J; Pavesio C; Agrawal R Ocul Immunol Inflamm; 2016; 24(1):16-23. PubMed ID: 26471249 [TBL] [Abstract][Full Text] [Related]
38. Scleritis: Immunopathogenesis and molecular basis for therapy. Wakefield D; Di Girolamo N; Thurau S; Wildner G; McCluskey P Prog Retin Eye Res; 2013 Jul; 35():44-62. PubMed ID: 23454614 [TBL] [Abstract][Full Text] [Related]
39. Comparative study of ophthalmological and serological manifestations and the therapeutic response of patients with isolated scleritis and scleritis associated with systemic diseases. Sousa JM; Trevisani VF; Modolo RP; Gabriel LA; Vieira LA; Freitas Dd Arq Bras Oftalmol; 2011; 74(6):405-9. PubMed ID: 22331111 [TBL] [Abstract][Full Text] [Related]